The time investment of 4 additional weeks at an intermediate dose is nothing compared to the setback of severe nausea that forces you to restart at a lower dose
Consumers should understand that marketing claims for these products often lack rigorous clinical validation
If theres one that your insurance does cover, then great, well start with that one. Trials have shown that on average tirzepatide leads to more weight loss than semaglutide, but different patients respond differently to different GLP-1 drugs
G., Mace, K
It is not intended for self-diagnosis, treat, cure, or prevent any disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 90.Cant C., Jiang L.Q., Deshmukh A.S., Mataki C., Coste A., Lagouge M., Zierath J.R., Auwerx J